Back to Results
First PageMeta Content
Endocrine system / Acetamides / Piperidines / Repaglinide / Guanidines / Metformin / Anti-diabetic medication / Novo Nordisk / Meglitinide / Diabetes / Chemistry / Organic chemistry


United States Court of Appeals for the Federal Circuit ______________________ NOVO NORDISK A/S AND NOVO NORDISK INC., Plaintiffs-Appellants,
Add to Reading List

Document Date: 2013-06-18 11:09:45

Open Document

File Size: 315,01 KB

Share Result on Facebook

City

Washington / DC / Chicago / /

Company

CARACO PHARMACEUTICAL LABORATORIES LTD. / See Novo Nordisk A/S / Caraco Pharm / STEFFEN 2 NOVO NORDISK A/S / Dunn & Crutcher LLP / NOVO NORDISK A/S / Pfizer / NOVO NORDISK INC. / HURST / Winston & Strawn LLP / /

Event

Legal Issues / Patent Filing / /

Facility

United States District Court / /

IndustryTerm

chemical qualities / pharmaceutical applications / pharmaceutical studies / black-letter law / concerns pharmaceuticals / large pharmaceutical manufacturer / /

MedicalCondition

non-insulin dependent diabetes mellitus / heart disease / noninsulin dependent diabetes mellitus / obesity / II diabetes / insulin resistance / disease / diabetes / NIDDM / /

MedicalTreatment

PROST / /

Organization

Food and Drug Administration / United States District Court for the Eastern District of Michigan / United States Court of Appeals / Medicare / Federal Government / UN Court / /

Person

JOSH A. KREVITT / WAYNE BARSKY / MICHEAL A. SITZMAN / DAVID S. BLOCH / Avern Cohn / MARK A. PERRY / LUCAS C. TOWNSEND / CHARLES B. KLEIN / Moses / N. JOHNSON / Richard Bork / ANDREW C. NICHOLS / JOHN K. HSU / /

Position

counsel / Circuit Judge / scientist / Judge / /

Product

Extended-Release Capsule / repaglinide / Cyclobenzaprine Hydrochloride / /

ProvinceOrState

Illinois / Michigan / /

SocialTag